| Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib TE Wiczer, LB Levine, J Brumbaugh, J Coggins, Q Zhao, AS Ruppert, ... Blood advances 1 (20), 1739-1748, 2017 | 166 | 2017 |
| Biomarkers of angiogenesis in colorectal cancer: Supplementary issue: Biomarkers for colon cancer L Mousa, ME Salem, S Mikhail Biomarkers in cancer 7, BIC. S25250, 2015 | 103 | 2015 |
| Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies KA Rogers, L Mousa, Q Zhao, SA Bhat, JC Byrd, Z El Boghdadly, ... Leukemia 33 (10), 2527-2530, 2019 | 85 | 2019 |
| Incidence and type of opportunistic infections during ibrutinib treatment at a single academic center KA Rogers, M Luay, Q Zhao, T Wiczer, L Levine, JS Blachly, JC Byrd, ... Blood 130, 830, 2017 | 35 | 2017 |
| Coronary artery bypass grafting (CABG) in patients with immune thrombocytopenia (ITP): a community hospital experience and review of the literature SJ Jubelirer, L Mousa, U Reddy, M Mir, CA Welch West Virginia Medical Journal 107 (6), 10-15, 2011 | 19 | 2011 |
| The majority of myeloma patients are vitamin D deficient, unrelated to survival or cytogenetics S Hudzik, B Snoad, L Mousa, DW Sborov, N Williams, D Jones, ... Blood 126 (23), 5336, 2015 | 9 | 2015 |
| Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha‐fetoprotein LA Sobotka, T Hake, C Kelly, L Mousa Clinical Case Reports 7 (2), 251, 2018 | 3 | 2018 |
| Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia S Khountham, P Shindiapina, X Mo, C Lachowiez, T Wiczer, L Mousa, ... Leukemia & Lymphoma 62 (3), 716-721, 2021 | 2 | 2021 |
| The impact of granulocyte colony-stimulating factor use in patients with metastatic breast cancer treated with palliative chemotherapy: a single-institution retrospective review L Mousa, JA Stephens, M Berger, B Ramaswamy, M Lustberg, S Sardesai, ... Supportive Care in Cancer 28, 5537-5545, 2020 | 2 | 2020 |
| Storytelling as a means of improving community and decreasing burnout in a large academic cancer center. SC Rogers, DM Benson, EH Kraut, TZ Haque, L Mousa, J Fowler, ... Journal of Clinical Oncology 38 (15_suppl), 11018-11018, 2020 | 1 | 2020 |
| An Atypical Case of Guillain-Barré Syndrome Associated With Gastrointestinal Stromal Tumor: 2552 A Chen, S Schubert, C Kelly, M Jin, L Mousa Official journal of the American College of Gastroenterology| ACG 112, S1392 …, 2017 | 1 | 2017 |
| Clinical and pathological characterization of patients (pts) with functional deficiency of the fanconi anemia (FA) pathway. S Mikhail, L Mousa, L Wei, W Duan, W Zhao, MA Villalona-Calero Journal of Clinical Oncology 34 (15_suppl), e23247-e23247, 2016 | | 2016 |
